Table 1 Medications available in Brazil for the treatment of IMID
Class | Drugs |
|---|---|
▪ Immunosuppressants | Azathioprine, calcineurin inhibitors, mofetil mycophenolate, cyclophosphamide |
▪ csDMARDs | Methotrexate, leflunomide, hydroxychloroquine, sulfasalazine |
▪ bDMARDs TNF inhibitors | Infliximab, etanercept, adalimumab, golimumab, certolizumab pegol |
▪ bDMARDs non-TNF inhibitors | Rituximab (anti-CD20), belimumab (anti-BlyS), anifrolumab (anti-IFN1), abatacept (anti-CD28), tocilizumab (anti-IL6r), secukinumab (anti-IL17), ixekizumab (anti-IL17), guselkumab (anti-IL23), risankizumab (anti-IL23), ustekinumab (anti-IL12/23), vedolizumab (anti-integrins) |
▪ tsDMARDs | Tofacitinib, baricitinib, upadacitinib |